A smaller dose can achieve the same holding weight steady with fewer side effects and lower cost
It is also considered for those with a BMI if they possess at least one, of 27 or more weight-related conditions, such as high cholesterol, high blood pressure, type 2 diabetes, or sleep apnea
The limitations stem from the retrospective nature of the study
Metabolism of [U-13C]glutamate in astrocytes studied by 13 C NMR spectroscopy: incorporation of more label into lactate than into glutamine demonstrates the importance of the tricarboxylic acid cycle
In November 2025, however, President Trump announced that Zepbound and other GLP-1s would be covered by Medicare starting as early as April 2026
You should always consult your doctor before starting, stopping, or changing your medication plan